Team Viz

Life Sciences

Jun 12, 2024

3 minutes

The Transformative Role of Point-of-Care AI in Pharma Commercial Strategy

While pharma is increasingly leveraging AI to derive data insights, enhance content development, and inform sales and marketing approaches, there remains a largely untapped potential for pharma companies to consider the ways AI is increasingly being used at the point of care and what this means for the pharma commercial model. In a recent MIT survey, 7 out of 10 healthcare institutions reported they’ve begun adopting AI in their activities, and more than 82% of healthcare business leaders report that their AI deployments have made meaningful improvements — saving healthcare professionals (HCPs) valuable time and allowing them to make decisions with more insight1. While pharma is increasingly investing in AI and with HCPs increasingly using AI in patient care decisions, there are immense possibilities for pharma to leverage point-of-care AI to drive patient-centricity as well as brand growth. In this article, we share some ways AI is providing value within the healthcare setting and what it means to pharma commercial teams.  

Addressing Healthcare Disparities: A Focus on Equity

One notable area gaining traction is the use of AI to address healthcare disparities, particularly among underserved communities. Through AI-driven solutions, we can identify and mitigate biases in healthcare delivery, ensuring safety and equitable healthcare for patients. For instance, by leveraging AI algorithms – tested across diverse patient data including age, sex, and race to help avoid bias – to analyze medical images and data, healthcare providers can better identify and treat diverse patient populations. Providers can then partner with community organizations, pharma and others to further offer patient support programs and ensure inclusivity.

Optimizing Workflows: Leveraging AI for Efficiency

Another value area is the adoption of AI technologies to optimize workflows within healthcare settings. Health systems are increasingly utilizing AI-driven solutions to overcome care gaps and streamline processes for HCPs and their organizations. By leveraging multimodal data, AI tools are transforming care delivery across various disease areas, offering benefits in efficiency and effectiveness, ensuring patients get diagnosed and access to the care and pharma treatments they need, faster — as we’ve seen with hypertrophic cardiomyopathy (HCM).

From Data to Insights: Harnessing AI for Better Healthcare

A significant value-add is using AI to derive actionable insights into the patient journey. With AI solutions, implemented at the point of care, HCPs, pharma, and other stakeholders can uncover and solve challenges in the patient journey, enabling earlier diagnosis, personalized treatment approaches, and improved patient monitoring and support. This has the potential to revolutionize healthcare delivery by providing HCPs with the tools and information they need, when they need it, to make informed and better care decisions.

Personalized Care: Enhancing the Patient Experience

Personalized care is emerging as a key opportunity in healthcare. By integrating data from various sources, HCPs, pharma, health plans and others can gain a holistic view of a patient’s health, enabling more timely interventions and better care. Patient-focused solutions, such as virtual health assistants and chatbots, are empowering patients with personalized education resources and support services, ultimately improving treatment adherence and enhancing the healthcare experience.

Looking Ahead: A Future Driven by AI

The rising role of point-of-care AI in pharma commercial strategy reflects a broader shift towards leveraging technology to enhance healthcare delivery, therefore ensuring more patients get access to the treatments they need. By thoughtfully and responsibly embracing and supporting AI initiatives that drive improvements in the care setting, we can unlock new possibilities and pave the way for a future where personalized, optimized and equitable healthcare is standard.

To discuss how a partnership with can help accelerate patient diagnosis and treatment for your pharma brand, contact us

Related content: Point-of-care AI: New Imperative for Pharma Commercial Strategy (

1. MIT Technology Review Insights. The AI effect: How artificial intelligence is making health care more human. 2023